Aprea Therapeutics (APRE) Q4 2023 Earnings

26MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-1.42
-1.2
-0.99
-0.77

Details

Expected EPS
-0.77
Actual EPS
-0.92
Surprise EPS
-0.15
Surprise Percent
+19.48%

Description

Aprea Therapeutics (APRE) has reported earnings of -0.92 per share for Q4 2023.

0 Comments

Share your thoughts